Clinical trials
Recruiting Carcinoma in Situ trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Protara Therapeutics | 2 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 1 |
| Children's Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| Huazhong University of Science and Technology | 1 |
| Lepu Biopharma Co., Ltd. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Michael A. O'Donnell | 1 |
| Olgun Elicin | 1 |
| OncoNano Medicine, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma in Situ | 12 |
| Non-Muscle Invasive Bladder Neoplasms | 6 |
| Urinary Bladder Neoplasms | 6 |
| Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Melanoma | 2 |
| Barrett Esophagus | 1 |
| Bites and Stings | 1 |
| Breast Carcinoma In Situ | 1 |
| Carcinoma, Lobular | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.